Julie‐Ann Francis

STING agonist therapy in combination with PD-1 immune checkpoint blockade enhances response to carboplatin chemotherapy in high-grade serous ovarian cancer

Abdi Ghaffari, Nichole Peterson, Kasra Khalaj et al. · British Journal of Cancer · 2018 · 193 citations · Full text

Life Sciences, Immunology, Oncology +17

STAT1‐associated intratumoural T_H1 immunity predicts chemotherapy resistance in high‐grade serous ovarian cancer

Katrina Au, Cécile Le Page, Runhan Ren et al. · The Journal of Pathology Clinical Research · 2016 · 55 citations · Full text

Medicine, Immunology, Oncology +17

CXCL10 alters the tumour immune microenvironment and disease progression in a syngeneic murine model of high-grade serous ovarian cancer

Katrina Au, Nichole Peterson, Peter Truesdell et al. · Gynecologic Oncology · 2017 · 51 citations

Medicine, Immunology, Oncology +17

Coping with fear of cancer recurrence among ovarian cancer survivors living in small urban and rural settings: A qualitative descriptive study

Jacqueline Galica, Janet Giroux, Julie‐Ann Francis et al. · European Journal of Oncology Nursing · 2019 · 39 citations

Medicine, Oncology, Oncology Nursing +15

Gastrointestinal Stromal Tumor Presenting as a Recurrent Vaginal Mass

Katherine M. Ceballos, Julie‐Ann Francis, J. Mazurka · Archives of Pathology & Laboratory Medicine · 2004 · 37 citations

Veterinary Medicine, Oncology, Pathology +16